Skip to main content

Welcome to Nino’s News. Our guest blogger, Anthony “Nino” Sireci, M.D. is vice president, clinical biomarker and diagnostics development, Loxo Oncology at Lilly. Dr. Sireci is a board-certified Clinical Pathologist and a practicing molecular pathologist. Prior to joining Loxo, he was an Assistant Professor of Pathology and Cell Biology at Columbia University and a medical director in the Laboratory of Personalized Genomic Medicine at Columbia Medical Center.


cancer medical care team

Understanding the Role of a Care Team in Treatment Planning

April 18, 2023
By: Anthony Sireci, M.D., senior vice president, clinical biomarkers and diagnostics development, Loxo@Lilly When someone…
lung cancer research

The Importance of Biomarker Testing When Facing RET-Altered Cancers

September 12, 2022
Over the last decade and a half, there has been a rapid expansion of precision…